GeneralConnection.com ➔ Dictionary
Dictionary Search

immunogen

Synonyms

Noun

1. immunizing agent

2. antigen

Usage
AbbVie's Immunogen buy delivers rare cancer drug approval - pharmaphorum
With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset - Fierce Pharma
When on-target misses the mark: Lessons from HIV immunogens - Fred Hutchinson Cancer Center
Immunogen-free CRISPR platform reveals metastatic drivers - CRISPR Medicine News
Immunogenic relationship mapping supports a minimal-set trivalent vaccine strategy for broad sarbecovirus protection - Nature
Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in mice - Science | AAAS
AbbVie sharpens immunology focus with $10.9 billion Apogee deal - Reuters
Molecular ingredients of an immunogen for long-lasting IgG - Frontiers
ELAHERE for the Treatment of Ovarian Cancer, US - Clinical Trials Arena
MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Camp - Business Wire
Antibodies induced by antigen-containing liposomes as immunogens preferentially recognize their antigens present on lipid vesicles - Nature
Simultaneous priming of HIV broadly neutralizing antibody precursors to multiple epitopes by germline-targeting mRNA-LNP immunogens in mouse models - Science | AAAS
AbbVie wraps up its $10.1B buyout of ImmunoGen well ahead of schedule - Fierce Pharma
AbbVie seeks lift from 'guided missile' cancer drug with $10 bln ImmunoGen deal - Reuters
Novel HIV-1 fusion peptide immunogens using glycan-engineered alphavirus-like particles - Nature
AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field - Fierce Pharma
C > U mutations generate immunogenic peptides in SARS-CoV-2 - Nature
StealTHY: An immunogen-free CRISPR platform to expose concealed metastasis regulators in immunocompetent models - Nature
DNA origami-based virus-like particles: a new class of HIV vaccine candidates with superior immunogenic properties - Nature
Protein engineering strategies for rational immunogen design - npj Vaccines - Nature
Inside AbbVie's $10B buyout of ImmunoGen—and the bidding war it swooped in on - Fierce Pharma
JP Morgan 2026 Preview: Rebuilding at AbbVie - Pharmaceutical Executive
Rational design of a ‘two-in-one’ immunogen DAM drives potent immune response against mpox virus - Nature
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion - CNBC
AbbVie to Acquire ImmunoGen With its Platinum-Resistant Ovarian Cancer Drug Elahere - Pharmaceutical Executive
Priming VRC01-precursor B cells with non-envelope immunogens disfavors boosting with HIV-1 envelope - Nature
AbbVie agrees $10.1bn deal to buy ImmunoGen - pharmaphorum
An engineered immunogen activates diverse HIV broadly neutralizing antibody precursors and promotes acquisition of improbable mutations - Science | AAAS
AbbVie Buys ImmunoGen in $10B Deal, Gains Access to ADC for Ovarian Cancer - BioSpace
FDA grants accelerated approval for ImmunoGen’s ovarian cancer ADC - Pharmaceutical Technology
Latham’s Antitrust Team Achieves Global Regulatory Approvals for AbbVie’s US$10.1 Billion Acquisition of ImmunoGen - Latham & Watkins LLP
AbbVie joins ADC dealmaking with $10B ImmunoGen buyout - BioPharma Dive
Use of equine H3N8 hemagglutinin as a broadly protective influenza vaccine immunogen - Nature
AbbVie Sees Early ROI on $10B Immunogen Buy in Phase II Ovarian Cancer Win - BioSpace
Pyxis brings in former ImmunoGen dealmaker to advance MICVO - Stock Titan
AbbVie buys Immunogen, maker of targeted cancer drugs, for $10 billion - STAT
AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer and Other Solid Tumors - Inside Precision Medicine
ImmunoGen drug prolongs survival of women with advanced ovarian cancer - STAT
Lilly reunites with ImmunoGen to expand into ADCs, paying $13M upfront and $1.7B on the back end - Fierce Biotech
Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen - Frontiers
AbbVie to Acquire ImmunoGen for $10.1B, Expanding Cancer Franchise - Genetic Engineering and Biotechnology News
Four decades in, ImmunoGen gets landmark green light in advanced ovarian cancer - Fierce Pharma
Engineered immunogen binding to alum adjuvant enhances humoral immunity - Nature
After AbbVie's ImmunoGen buy, Elahere posts midstage trial win in ovarian cancer subtype - Fierce Pharma
ImmunoGen Stock Soars 80% on AbbVie's $10 Billion Takeover - Barron's
ImmunoGen’s drug Elahere offers hope for ovarian cancer patients - Clinical Trials Arena
AbbVie Pays $10.1 Billion for ImmunoGen to Expand Its Cancer Drug Portfolio - Investopedia
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies - Nature
AbbVie to acquire ADC manufacturer ImmunoGen for $10.1B in oncology play - Medical Marketing and Media
Vertex pays ImmunoGen $15M to use antibody-drug conjugates to improve CRISPR therapy - Fierce Biotech
Rabies virus large protein-derived T-cell immunogen facilitates rapid viral clearance and enhances protection against lethal challenge in mice - Nature
Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope - Nature
Germline-targeting immunogens guide bnAb development - Nature
AbbVie diversifies oncology portfolio with $10.1 bn ImmunoGen acquisition - Pharmaceutical Technology
ImmunoGen Announces Conference Call to Discuss Its 2022 Operating Results - Business Wire
Immunogen wins FDA approval for targeted medicine to treat advanced ovarian cancer - STAT
ImmunoGen (IMGN) Soars 5.7%: Is Further Upside Left in the Stock? - Yahoo Finance
ImmunoGen Secures $200M Partial Sale of Royalty Interest in Kadcyla with “Cap and Tail” - Mintz
AbbVie to Acquire ImmunoGen in Deal Valued at $10.1 Billion - BioPharm International
Simulation-driven design of stabilized SARS-CoV-2 spike S2 immunogens - Nature
Engineered immunogens to elicit antibodies against conserved coronavirus epitopes - Nature
For ImmunoGen, persistence pays off as FDA clears ovarian cancer drug - BioPharma Dive
ImmunoGen’s commitment to Elahere pays off with $10.1B AbbVie takeout - biocentury.com
AbbVie to Acquire ImmunoGen in $10.1B Deal - Contract Pharma
Mosaic HIV immunogens boost the breadth of vaccine immune responses - European AIDS Treatment Group
Federal Circuit Affirms ImmunoGen Patent Obviousness - ArentFox Schiff
ImmunoGen to lay off 220 workers, as it pushes ahead with troubled drug - BioPharma Dive
AbbVie ADC bolster with $10bn ImmunoGen bid - BioProcess Insider - BioProcess International
Takeda collaborates with ImmunoGen for ELAHERE - Pharmaceutical Technology
AbbVie concludes acquisition of ImmunoGen for $10.1bn - Pharmaceutical Technology
ImmunoGen ELAHERE wins accelerated FDA approval for ovarian cancer - pharmaphorum
ImmunoGen’s ADC Elahere wins FDA priority review for ovarian cancer - Pharmaceutical Technology
AbbVie Sells $15 Billion of Bonds to Buy ImmunoGen, Cerevel - Bloomberg.com
ImmunoGen’s ADC misses endpoint in ovarian cancer phase 3 - Fierce Biotech
Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection - Nature
AbbVie to spend $10.1B to acquire ImmunoGen, 43-year-old Waltham biotech - The Business Journals
ImmunoGen Sued Over Alleged Omissions in AbbVie Buyout Proxy - Bloomberg Law News
ImmunoGen wins new chance to receive patent on ovarian cancer treatment - Reuters
Improvement of a SARS-CoV-2 vaccine by enhancing the conjugation efficiency of the immunogen to self-assembled nanoparticles - Nature
ImmunoGen, Inc. Announces $200 Million Non-Dilutive Royalty Transaction - TPG Inc.
Rational engineering of minimally immunogenic nucleases for gene therapy - Nature
Lilly revives ImmunoGen ADC pact with new $1.7bn deal - pharmaphorum
IAVI Researchers Publish Study on Antibody Responses to HIV Immunogen in Non-human Primates - IAVI
Q&A: Mark Enyedy, ImmunoGen - Pharmaceutical Executive
AbbVie's $10B ImmunoGen deal was won by paying $7 a share over a rival bidder's offer, SEC filings show - Endpoints News
Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies - Science | AAAS
AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why - The Motley Fool
Wachtell, Ropes & Gray Advise Abbvie, ImmunoGen on Acquisition - Bloomberg Law News
ImmunoGen Licenses Cancer Compounds to Sanofi - Genetic Engineering and Biotechnology News
ImmunoGen touts 'home run' as ovarian cancer drug Elahere extends lives in landmark trial win - Fierce Pharma
AbbVie mum on plans for ImmunoGen employees, HQ - The Business Journals
Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize Antibody-Drug Conjugate Products - PR Newswire
Amid Waves of Biotech Layoffs, ADC Developers like ImmunoGen are Thriving - BioSpace
Structure-based design of a Plasmodium vivax Duffy-binding protein immunogen focuses the antibody response to functional epitopes - Wiley Online Library
ImmunoGen, Takeda Partner to Commercialize ELAHERE in Japan - Contract Pharma
Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine design - Nature
ImmunoGen sells off ADC to Debiopharm - BioPharma Dive
A Rapid Virus-Free Method for Producing Influenza HA Immunogen Needed for Preparation of Influenza Vaccine Potency Antisera Reagents - Wiley Online Library
ImmunoGen Announces FDA Accelerated Approval of ELAHERE™ (mirvetuximab soravtansine-gynx) for the Treatment of Platinum-Resistant Ovarian Cancer - Business Wire
ImmunoGen commercial chief to withdraw before drug launch - Medical Marketing and Media
Foreign Language Equivalents
Foreign Language Equivalents of 'immunogen'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
immunigen,   immnogen,   mmunogen,   immunoge,   imunogen,   inmunogen,   imumnogen,   i,munogen,   immmunogen,   imunogen,   immnuogen,   ummunogen,   immunoegn,   immunnogen,   imnunogen,   immunohen,   immunogwn,   immuunogen,   immunogne,   imminogen,   immunogem,   immynogen,   immubogen,   immungen,   immunogn,   immuongen,   immumogen,   immungoen,   immunogeen,   immunogeb,   iimmunogen,   immunoogen,   immunpgen,   immunoen,   immunoggen,   immunogrn,   immmunogen,   ommunogen,   immunofen,   mimunogen,   immunogenn,   immuogen,   im,unogen
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z